Research finds no evidence linking common drug to autism

Date:

Share this article:

Del denne artikel:

A major Danish study finds no evidence linking common pain relief during pregnancy to autism risk.

You read the warnings, hear the debates, and suddenly even familiar choices feel uncertain.

For many expectant parents, decisions about everyday medication can quickly become a source of concern.

According to MedPage Today, reporting on research published in JAMA Pediatrics by Kira Philipsen Prahm and colleagues at Copenhagen University Hospital Rigshospitalet, one of the most discussed questions has now been examined using extensive Danish data.

A long-running debate

The safety of acetaminophen during pregnancy has been widely debated in recent years. Concerns have circulated about a possible link to developmental conditions, including autism.

Also read: This happens to your body if you eat blackberries every day

To investigate this, researchers analyzed nationwide data covering more than 1.5 million children born in Denmark over a 25-year period.

What the findings show

The results were consistent across multiple approaches. No meaningful association was found between prenatal exposure to acetaminophen and autism in children.

This held true regardless of how exposure was assessed:

  • Timing during pregnancy
  • Dosage levels
  • Comparisons between siblings

These findings suggest that earlier concerns may have been influenced by other underlying factors rather than the medication itself.

Also read: Hidden bone disease affects 40 percent of adults worldwide – are you one of them?

A consistent picture

Similar studies conducted in other countries have reached comparable conclusions, strengthening the overall evidence base.

Researchers emphasize that when results are repeated across large populations and different methods, confidence in the findings increases.

Overall, the study indicates that this commonly used medication does not appear to raise the risk of autism when used during pregnancy.

Also read: Study: New migraine treatments could cut monthly attacks

Also read: New cell technology could repair damaged knees

This article is made and published by Mie Hermansen, who may have used AI in the preparation.

Other articles

Taking Ozempic or Wegovy? The FDA just added a vision-loss warning to the label

Behind the label change is a single eye condition and a rate that quietly doubled compared with the trials' control groups.

Five breathing techniques that may calm anxiety in just a few minutes

All five patterns have research behind them, but one stood out for how fast it works.

How eating tomatoes every day may affect your heart and cancer risk

A cheap kitchen staple keeps showing up in major heart and cancer reviews, and the daily amount is smaller than you'd expect.

What your gums can reveal about your heart health and disease risk

What a dentist spots at your next checkup may say something about the blood vessels around your heart, not just about your teeth.

Taking Ozempic or Wegovy? The FDA just added a vision-loss warning to the label

Behind the label change is a single eye condition and a rate that quietly doubled compared with the trials' control groups.

Five breathing techniques that may calm anxiety in just a few minutes

All five patterns have research behind them, but one stood out for how fast it works.

How eating tomatoes every day may affect your heart and cancer risk

A cheap kitchen staple keeps showing up in major heart and cancer reviews, and the daily amount is smaller than you'd expect.